Sign in

Data Entry Clinical Research

Seattle, WA
March 23, 2018

Contact this candidate



***** ** ***** **, **** Washington USA 98042.

Contact: US 253-***-**** India +919*********, +919*********,


Diligent, dedicated and result-oriented professional with 29+ years of accomplished experience in the Research and Development sector, in the field of Thalassemia and Hemoglobinopathies - Biochemical and Molecular Genetics. Possessing keen interest in Epigenetic & Gene Expression. Pragmatic, with proven managerial acumen and abilities to withstand work pressures, deliver assignments within specified time frame without compromising on quality benchmarks. Seeking challenging assignments as Research Coordinator.

§Proven expertise in research and publishing findings, analyze/evaluate data & results and perceive patterns/structures.

§Well versed with the basic techniques of biotechnology with theoretical and practical knowledge in microbiology, biochemistry & immunology.

§Expertise in identifying issues, forming hypothesis, designing and conducting analysis, synthesizing conclusions into recommendations and implementing change.

§Adept in managing the entire gamut of Laboratory Unit Operations along with vendor development & evaluation, conducting internal quality audits, managing the maintenance of laboratory equipment, Production Planning, conducting Inspection/Tests for checking the quality of products and maintaining working standards as per requirements and standardization

§Strong communication, collaboration & team building skills with proficiency at grasping new technical concepts quickly


D.Sc. (Indo Allopathy), Kolkata,2016

MBA (Clinical Research) Mumbai, 2016.

D.Sc. (Biochemistry) Bombay University, India, Submitted

(Topic of Thesis- Prevention and Control of Thalassaemia & Haemoglobinopathies in India)

M.D. (Pathology), Indian Board of Alternative Medicine, Kolkatta,2006

Ph.D. (Applied Biology) Bombay University, India, 2004

(Topic of Thesis- Haematological, biosynthetic and molecular studies on alpha thalassaemia syndromes in India)

MBBS, Indian Board of Alternative Medicine, Kolkata, 2002.

M. Sc. (Applied Biology) Bombay University, India, 1988

(Topic of Thesis- Usefulness of globin chain electrophoresis for the detection of thalassemia at birth)

B. Sc. (Microbiology) Bombay University, India, 1982


King Faisal University, Saudi Arabia Ast. Professor of Pathology 2/2009 – 8/ 2011

National Institute o f Immunohematology, Mumbai Technical Officer 4/ 2008 - 2009

Institute o f Immunohematology, Mumbai Research Assistant 1/ 1990 – 3/2008


Computer skills: Microsoft word, Microsoft excell, Microsoft Power point, Microsoft access, Microsoft outlook, data entry

Statistical skills: Mean, Standard deviation, Coefficient of variation, chi square test, F-test, p- value, t-test, Sensitivity, Specificity, Efficiency, Predictive value, Regression coefficient etc

Biochemical Technology: Enzyme & substrate Assays, Blood biochemistry, Globin chain synthesis Electrophoresis, Chromatography, PAGE, ELISA etc

Microbiological technology: Staining, Culture, Transformation of bacteriophages

Molecular biological technology: DNA extraction, Polymerase chain reaction, Southern and Northern Blotting, Transformation bacteriophages, Covalent reverse dot blot hybridization, etc


§Established different electrophoretic techniques for identification of abnormal hemoglobins (Hbs) and unstable Hbs in a at risk population using cellulose acetate, starch gel, agar gel, disc and thin layer polyacrylamide gel electrophoresis, isoelectric focusing and Hemoglobin Variant System Kit of BIORAD.

§Participated in the multi-centric ICMR (Indian Council of Medical Research) task force project on "Collaborative study of thalassemia" where a large survey of thalassemia and its variants in high school children in Bombay was undertaken along with cord blood screening for a-thalassemia.

§Established the first center in India for Prenatal diagnosis of thalassemia in the second trimester by fetal blood analysis (globin chain synthesis and isoelectric focusing).

§Established approaches for first trimester prenatal diagnosis of hemoglobinopathies on chorionic villus tissue samples by DNA analysis using PCR based approaches.

§Actively involved in control of Thalassemia & Hemoglobinopathies by Community service, awareness program and public education.

§Established Al Omran Chair Research Laboratory and taught Molecular Biology technology to the technical staff of King Faisal University.


Academic Responsibilities:

§Teaching Pathology (both Theory and Practical) to undergraduate medical college students of King Faisal University.

§Experience in managing research projects and collaborative relationship through NIIH Mumbai.

§Responsible for teaching biochemical and molecular biology technics to post graduates and doctorate students of Mumbai University.

Research Responsibilities

§Actively involved in various research projects on Hemoglobinopathies and Erythroenzymopathies leading to identification of some interesting cases such as Homozygous HPFH (first time in India), Homozygous Hb Q (first time in the World), Hb JParis, very rare entity Hb H disease, Hb Lepore, Hb Showa Yakushiji, Hb MRatnagiri, Hb DAgri, Hb DIran etc.

§Developed second trimester prenatal diagnosis of thalassemia and hemoglobinopathies by globin chain synthesis technique.

§Developed first trimester prenatal diagnosis of thalassemia and hemoglobinopathies by chorionic villus tissue analysis by molecular techniques.

§Established VTNR studies for detection of maternal contamination in chorionic villus samples in prenatal diagnosis of hemoglobinopathies; the detection of paternity dispute whenever the mutation in chorionic villus samples in prenatal diagnosis of hemoglobinopathies does not match with father’s mutation; for checking of acceptance of bone marrow transplantation done for hemoglobinopathies and leukemia patients; the rare tribes and caste groups of India viz Parsi, Lohana or Great Andamanese - A primitive Negrito tribe of Andaman and Nicobar Islands, India.

§Helped in developing covalent reverse dot blot technology for b-thalassaemia mutations detection and now Patent granted in January 2005 (No.194149).

§Methylation studies in acute myeloid leukemia.




Conferences, seminars attended and presented

Published abstracts



DOB: 15th April 1962

Languages Known: English, Hindi, Marathi

Availability: Immediately

Location: Willing to relocate

Contact this candidate